SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Drugs - Quaterly Results

13 Feb 2024 Evaluate
The sales slipped to Rs. 126.24 millions for the December 2023 quarter as against Rs. 135.27 millions during the year-ago period.The Net Loss for the quarter ended December 2023 is Rs. -2.39 millions as compared to Net Profit of Rs. 4.54 millions of corresponding quarter ended December 2022The company reported a degrowth in operating Profit to 5.62 millions from 14.45 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 126.24 135.27 -6.68 288.02 397.82 -27.60 513.23 590.57 -13.10
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 5.62 14.45 -61.11 34.97 36.13 -3.21 43.52 56.94 -23.57
Interest 4.32 4.49 -3.79 12.12 12.07 0.41 16.25 16.81 -3.33
PBDT 1.30 9.96 -86.95 22.85 24.06 -5.03 27.27 40.13 -32.05
Depreciation 3.85 3.80 1.32 11.48 12.96 -11.42 16.03 17.65 -9.18
PBT -2.55 6.16 -141.40 11.37 11.10 2.43 11.24 22.48 -50.00
TAX -0.16 1.62 -109.88 3.63 2.86 26.92 2.33 6.54 -64.37
Deferred Tax -0.11 -0.05 120.00 -0.54 -0.38 42.11 -1.14 -0.18 533.33
PAT -2.39 4.54 -152.64 7.74 8.24 -6.07 8.91 15.94 -44.10
Equity 100.00 87.44 14.36 100.00 87.44 14.36 93.16 87.44 6.54
PBIDTM(%) 4.45 10.68 -58.33 12.14 9.08 33.69 8.48 9.64 -12.05

Concord Drugs Share Price

85.99 3.60 (4.37%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×